Skip to content

Dr. Sofie Demasure, oncoloog

Active Private limited companyfounded 2022active for 4 yearsVeldstraat 126, 8500 KortrijkKBO/BCE: BE 0788.497.459

Timeline

10 events since 2022

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 31 days before the deadline
2025
Highest result from 2023 to 2025 net €426,796 ▲96.2% The operating result of €557,666 and the net result of €426,796 are both a record.
Equity above €500,000 equity €800,446 ▲114% With a profit in every financial year since 2023, equity grows to €800,446.
Annual accounts 2024 filed PDFmicro format · 19 days before the deadline
2024
Liquidity more than doubled current ratio 7.75 The current ratio rises from 3.68 to 7.75. Short-term debt falls from €58,254 to €53,857.
Equity above €200,000 equity €373,651 ▲139% With a profit in every financial year since 2023, equity grows to €373,651.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0788497459
Annual accounts 2023 filed PDFmicro format · 21 days before the deadline
2022
IncorporationFounding capital of €3,000, 100 shares · Founded by · appointed as director · published on 14-07-20225 points ▸
  • Founded by
  • The founding capital is €3,000, divided into 100 shares
  • The registered office is at Kortrijk, Veldstraat 126
  • The board has one director
  • appointed as director
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

First establishment Veldstraat 126, Kortrijk

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Dr. Sofie Demasure, oncoloog was incorporated on 12 July 2022 as a private limited company by one private individual, with a starting capital of €3,000.12 is director of the company, appointed by deed of 14-07-2022.2 Total assets rose from €214,402 in 2023 to €857,265 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 14-07-2022
  3. 3National Bank, annual accounts 2023 and 2025

Next steps